Omri Casspi Secures $250 Million in Latest Pre-Seed Funding Round
Omri Casspi secured $250 million in its latest Pre-Seed, adding another data point to the Healthcare & Life Sciences funding market.
Omri Casspi Raises $250 million in Funding
Omri Casspi raises $250 million after big wins with Cognition, Wonderful and Upwind. An Israeli biotech is betting they can "If you're building a frontier technology, then you don't have growth" Omri Casspi.
Investors Behind the Funding
The round was backed by seed through growth. Capvizr tracks this investor activity alongside sector momentum, co-investor patterns, and recent comparable raises.
Company Profile and Market Context
Omri Casspi operates in Healthcare & Life Sciences. Omri Casspi's financing adds to recent private-market activity.
Strategic Use of Funds
$800 million.
Looking Ahead
Omri Casspi raises $250 million after big wins with Cognition, Wonderful and Upwind
Source reference: original announcement/article.
View Omri Casspi's full profile and funding history on Capvizr →